Holen Sie sich die Stockscreener-App
16.68
0.60%
0.10
Handel nachbörslich:
16.68
Schlusskurs vom Vortag:
$16.58
Offen:
$16.65
24-Stunden-Volumen:
84,871
Relative Volume:
1.05
Marktkapitalisierung:
$214.38M
Einnahmen:
$16.96M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-7.9542
EPS:
-2.097
Netto-Cashflow:
$-20.66M
1W Leistung:
-0.03%
1M Leistung:
-0.24%
6M Leistung:
-7.28%
1J Leistung:
-18.11%
1-Tages-Spanne:
$16.37
$16.86
1-Wochen-Bereich:
$16.37
$17.10
52-Wochen-Spanne:
$14.90
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
16.68 | 213.09M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
(MDWD) Risk Channels and Responsive Allocation - Stock Traders Daily
Mediwound Ltd expected to post a loss of 65 cents a shareEarnings Preview - TradingView
MediWound Ltd. (MDWD) Holds Near Support as Minor Decline Tests Key FloorShared Momentum Picks - Newser
MDWD PE Ratio & Valuation, Is MDWD Overvalued - Intellectia AI
MediWound Ltd. (MDWD) Presents at European Wound Management Association (EWMA) 2026Slideshow - Seeking Alpha
[SCHEDULE 13G] MediWound Ltd. Passive Investment Disclosure (>5%) - Stock Titan
TradingKey - TradingKey
(MDWD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The real story behind MediWound (MDWD) valuation (Trend Weakens) 2026-05-08Gap Up Stocks - newser.com
MediWound to Report First Quarter 2026 Financial Results - Moomoo
MDWD Technical Analysis & ETF Price Forecast - Intellectia AI
May 27 at 8:30 a.m.: MediWound to discuss Q1 results, update - Stock Titan
MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting - TipRanks
MediWound | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] - Moomoo
Strong MediWound (MDWD) support for board and proposals at 2026 meeting - Stock Titan
MediWound | 20-F: FY2025 Annual Report - Moomoo
Liquidity Mapping Around (MDWD) Price Events - Stock Traders Daily
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Analysts - MarketBeat
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market - TipRanks
Why (MDWD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Is MediWound (MDWD) stock forming a trend channel (Technical Weakness) 2026-04-20Income Investing - Cổng thông tin điện tử tỉnh Lào Cai
Shmuel Hess Net Worth (2026) - GuruFocus
Vickie Rae Driver Net Worth (2026) - GuruFocus
Kalfon Hana Luxenburg Net Worth (2026) - GuruFocus
Ety Klinger Net Worth (2026) - GuruFocus
Yaakov Aya Ben Net Worth (2026) - GuruFocus
MediWound highlights consensus supporting debridement strategy By Investing.com - Investing.com Australia
Breakouts Watch: Will MediWound Ltd benefit from sector rotation2026 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn
MediWound Highlights U.S. Expert Consensus Supporting EscharEx® Strategy for Chronic Wound Debridement - Quiver Quantitative
MediWound highlights consensus supporting debridement strategy - Investing.com
U.S. wound experts favor less invasive care, aligning with MediWound - Stock Titan
Understanding Momentum Shifts in (MDWD) - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Published on: 2026-04-11 10:40:16 - baoquankhu1.vn
Wound Care Biologics Market Is Going to Boom | MediWound Ltd. • Acelity L.P. Inc. • Smith & Nephew plc - openPR.com
MediWound Ltd. (M8W.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25 - Moomoo
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - Sahm
MDWD SEC FilingsMediwound 10-K, 10-Q, 8-K Forms - Stock Titan
Mediwound Ltd. Presents New Escharex Data At Wound Care Conferences - marketscreener.com
Why Vericel (VCEL) Is Up 11.8% After Landing Long-Term BARDA Deal For NexoBrid - simplywall.st
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million - Sahm
MediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
MediWound (MDWD) Gains as Vericel Secures $197M Contract for Nex - GuruFocus
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid - TipRanks
BARDA’s up-to-$197M NexoBrid contract highlighted by MediWound (MDWD) - Stock Titan
U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
Aug Highlights: Is MediWound Ltd forming a bullish divergence2026 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus - The Globe and Mail
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):